Home › Lung Cancer › NCT07615764
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
Lung Health Promotion for AI/AN People Through Human Center Design (Lung PATHS) - Aim 3 Intervention
Who can join
Ages 50 to 80 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Between ages 50-80 * Self-identify as AI/AN * Self-reported 10 pack-year smoking history (commercial tobacco i.e. cigarettes) * Ability to understand and indicate informed consent Exclusion Criteria: * Not between ages 50-80 * Having less than a 10 pack-year history of smoking commercial tobacco * Inability to communicate in written and verbal English * Having any cognitive impairment that compromises the ability to provide informed consent
About the study
This clinical trial evaluates the acceptability and effectiveness of an educational intervention (Lung Toolkit) for improving knowledge about lung cancer and lung cancer screening among American Indian/Alaskan Native (AI/AN) cigarette smokers. The Lung Toolkit is an educational intervention, including a website and a physical artifact pouch, specifically tailored to the needs of AI/AN individuals. The website includes evidence-based resources about lung health and lung cancer screening, facts about commercial tobacco and traditional tobacco, national and local smoking cessation and screening resources, and community-building resources such as stories from AI/AN community members about their experiences with lung cancer screening and smoking cessation. The physical artifact pouch links to the website with a quick response code and contains ceremonial herbs and motivational messaging around smoking cessation and lung cancer screening. The Lung Toolkit intervention may be effective for improving knowledge about lung cancer screening and commercial tobacco cessation in AI/AN populations.
What is being tested
- Educational Intervention (other)
- Educational Intervention (other)
- Interview (other)
- Questionnaire Administration (other)
Sponsor: Fred Hutchinson Cancer Center · Participants: 60 · Started: Dec 1, 2026
Contact the study team
- Nicolas Anderson · Phone: 206.667.5434
Official record on ClinicalTrials.gov — NCT07615764
Locations in the U.S.
| Washington | Fred Hutch/University of Washington Cancer Consortium, Seattle |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.